Upfront autologous hematopoietic stem cell transplantation consolidation for patients with aggressive B‐cell lymphomas in first remission in the rituximab era: A systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2019 at "Cancer"
DOI: 10.1002/cncr.32464
Abstract: The outcomes for patients with diffuse large B‐cell lymphoma (DLBCL) with adverse clinical prognostic factors such as a high age‐adjusted International Prognostic Index (aaIPI) are not optimal. In the current study, the authors performed a… read more here.
Keywords: review meta; systematic review; autologous hematopoietic; hematopoietic stem ... See more keywords
Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma
Sign Up to like & getrecommendations! Published in 2020 at "Cancer"
DOI: 10.1002/cncr.33171
Abstract: Upfront autologous hematopoietic stem cell transplantation (AHCT) remains an important therapy in the management of patients with multiple myeloma (MM), a disease of older adults. read more here.
Keywords: autologous hematopoietic; multiple myeloma; cell transplantation; age bar ... See more keywords
A prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantation
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34444
Abstract: Dysgeusia is a common but understudied complication in patients undergoing autologous hematopoietic cell transplantation (auto‐HCT). We assessed the feasibility of using chemical gustometry (CG) to measure dysgeusia and explored its associations with symptom burden, nutrition,… read more here.
Keywords: dysgeusia; hematopoietic cell; autologous hematopoietic; cell transplantation ... See more keywords
Inefficacy of Rituximab Post-Autologous Hematopoietic Stem Cell Transplant to Prevent Relapses in Persons with Multiple Sclerosis
Sign Up to like & getrecommendations! Published in 2019 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2018.12.515
Abstract: Background In an effort to reset the immune system, individuals with multiple sclerosis (MS) have undergone autologous hematopoietic stem cell transplant; this approach has produced promising results in terms of feasibility, efficacy and safety, however,… read more here.
Keywords: stem cell; autologous hematopoietic; cell transplant; rituximab ... See more keywords
Outcomes of Autologous Hematopoietic Stem Cell Transplantation in Elderly Multiple Myeloma Patients - a Single Network Experience.
Sign Up to like & getrecommendations! Published in 2020 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2019.12.476
Abstract: Introduction Determining eligibility for autologous hematopoietic stem cell transplantation (Auto-HCT) is considered standard of care for patients with newly diagnosed multiple myeloma (MM). In addition to comorbidity score, age >65 years is still a commonly… read more here.
Keywords: autologous hematopoietic; transplantation; hct; day ... See more keywords
Efficacy of Proteasome Inhibitor-Based Maintenance Post Autologous Hematopoietic Cell Transplant in Multiple Myeloma: A Systematic Review and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2020 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2019.12.493
Abstract: Background Autologous hematopoietic cell transplantation (AHCT) followed by maintenance therapy is the current standard of care in the treatment of multiple myeloma (MM). Lenalidomide (Len) is most commonly utilized as maintenance therapy as it has… read more here.
Keywords: based maintenance; maintenance; systematic review; hematopoietic cell ... See more keywords
Long-term outcomes of nonmyeloablative autologous hematopoietic stem cell transplantation in multiple sclerosis
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the Neurological Sciences"
DOI: 10.1016/j.jns.2019.10.842
Abstract: Background Although there is no effective cure for this disease, high-dose chemotherapy (HDCT), together with autologous hematopoietic stem cell transplantation (auto-HSCT) offers promising results in the treatment of multiple sclerosis (MS) patients. Methods In this… read more here.
Keywords: cell transplantation; autologous hematopoietic; stem cell; transplantation ... See more keywords
Recent advances and remaining questions of autologous hematopoietic stem cell transplantation in multiple sclerosis
Sign Up to like & getrecommendations! Published in 2021 at "Journal of the Neurological Sciences"
DOI: 10.1016/j.jns.2021.117324
Abstract: The judicious use of autologous hematopoietic stem cell transplantation (AHSCT) for MS requires understanding the potential benefits, identifying the most appropriate patient, and acknowledging the risks and differences between different protocols. Recently, AHSCT for MS… read more here.
Keywords: cell transplantation; autologous hematopoietic; stem cell; hematopoietic stem ... See more keywords
Can multiple sclerosis be cured? A case of highly active relapsing multiple sclerosis treated with autologous hematopoietic stem-cell transplantation 13 years ago.
Sign Up to like & getrecommendations! Published in 2020 at "Multiple sclerosis and related disorders"
DOI: 10.1016/j.msard.2020.102253
Abstract: A 26-year-old man, with five years of highly active deteriorating relapsing multiple sclerosis (MS), unresponsive to conventional therapy, was treated with autologous hematopoietic stem-cell transplantation (AHSCT) 13 years ago. Since then the patient had no… read more here.
Keywords: sclerosis; autologous hematopoietic; highly active; multiple sclerosis ... See more keywords
Trajectories of Fasting Blood Glucose in Autologous Hematopoietic Cell Transplantation.
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Nursing"
DOI: 10.1097/ncc.0000000000000627
Abstract: BACKGROUND Patients who receive autologous hematopoietic cell transplantation (HCT) for the treatment of hematologic malignancies are at risk of serious adverse outcomes including infections and death. Hyperglycemia following the HCT is associated with increased risk… read more here.
Keywords: autologous hematopoietic; hematopoietic cell; hct; blood glucose ... See more keywords
Autologous Hematopoietic Stem Cell Transplantation for Liver Transplant Recipients With Recurrent Primary Sclerosing Cholangitis: A Pilot Study
Sign Up to like & getrecommendations! Published in 2021 at "Transplantation"
DOI: 10.1097/tp.0000000000003829
Abstract: Background. Primary sclerosing cholangitis (PSC) is an indication for liver transplantation, but recurrence after liver transplantation is associated with poor outcomes often requiring repeat transplantation. We investigated whether autologous hematopoietic stem cell transplantation (aHSCT) could… read more here.
Keywords: autologous hematopoietic; liver; transplantation; cell ... See more keywords